Ovoca Bio | OVG - Net Income


Ovoca Bio reported EUR-765K in Net Income for its fiscal semester ending in June of 2025.





Net Income Change Date
Akebia Therapeutics USD -12.24M 12.78M Dec/2025
Alaunos Therapeutics USD -1.16M 108K Sep/2025
ALKERMES USD 49.34M 33.42M Dec/2025
Avita Medical AUD -11.62M 1.7M Dec/2025
Dianthus Therapeutics USD -64.43M 27.67M Dec/2025
Great Western Mining Corporation EUR -485.23K 42.76K Jun/2025
Ionis Pharmaceuticals USD -229M 100.39M Dec/2025
IQVIA Holdings USD 514M 183M Dec/2025
Malin Corporation EUR -1.1M 2.2M Dec/2023
Moderna USD -200M 625M Sep/2025
Organon & Co USD 160M 15M Sep/2025
Ovoca Bio EUR -765K 4.89M Jun/2025
Revvity USD 98.36M 51.71M Dec/2025
Tectonic Therapeutic USD -19.23M 186K Dec/2025
Viatris USD -340.1M 211.9M Dec/2025
Xeris Pharmaceuticals USD 11.08M 10.46M Dec/2025